Investigates miR-125a's role in reducing inflammation and enhancing lipid synthesis in bovine mammary epithelial cells, indicating therapeutic potential.
Bovine mastitis, a major dairy disease, involves inflammation and metabolic dysfunction in mammary epithelial cells (bMECs); however, the regulatory role of microRNAs remains unclear. This study investigated miR-125a in LPS-induced bMECs. miR-125a was downregulated in inflamed bovine mammary tissue and LPS-induced bMECs. Overexpression of miR-125a inhibited pro-inflammatory cytokine release, upregulated proliferation markers, downregulated apoptosis markers, and alleviated oxidative stress. IL6R (interleukin-6 receptor) was identified as a direct target of miR-125a via transcriptome sequencing and dual-luciferase assays. miR-125a suppressed inflammation by targeting IL6R, thereby inhibiting NF-κB pathway activation. Rescue experiments showed miR-125a reversed IL6R-exacerbated inflammation and restored milk fat synthesis-related gene expression and triglyceride accumulation. In vivo mouse experiments confirmed IL6R's pro-inflammatory and milk fat-suppressing effects. Thus, this study elucidates the miR-125a/IL6R/NF-κB axis in coordinately regulating inflammation and milk fat synthesis in bovine mastitis, offering insights for targeted therapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: